BioProject,Run,EV_type,Source,disease,Disease_stage/treatment,Release_date,URL,EV isolated method,Project_Title,Project_Description
PRJEB34442,ERR3523233,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523234,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523235,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523236,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523237,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523238,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
PRJEB34442,ERR3523239,sEV,Endometrial-Derived Mesenchymal Stem Cells|Primary cell|Uterus,-,-,2019-11-17,https://pubmed.ncbi.nlm.nih.gov/31921832/,-,EV-endMSC,"Endometrial-derived Mesenchymal Stem Cells are one of the most promising candidates for stem cell-based therapies. Here we hypothesize that extracellular vesicles released by these cells may have a promising therapeutic effect, especially, those vesicles derived from IFNγ primed cells. Based on this hypothesis, here we have characterized the proteomic and the miRNAs profile of these vesicles."
